Intangible Assets

9 Months Ended

Jul. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill


(In millions)	CooperVision		CooperSurgical		Total



Balance at October 31, 2021	$	1,841.0	$	733.0	$	2,574.0
Current period additions	0.8		1,205.4		1,206.2
Foreign currency translation adjustment	(99.0)		(15.4)		(114.4)
Balance at July 31, 2022	$	1,742.8	$	1,923.0	$	3,665.8

The Company evaluates goodwill for impairment annually during the third quarter of the fiscal year and when an event occurs or circumstances change such that it is reasonably possible that impairment may exist. The Company accounts for goodwill, evaluates and tests goodwill balances for impairment in accordance with related accounting standards.

Qualitative factors considered in the assessment include industry and market considerations, overall financial performance and other relevant events and factors affecting each reporting unit. Based on the Company's qualitative assessment, if the Company determines that the fair value of a reporting unit is more likely than not to be less than its carrying amount, the fair value of the reporting unit will be compared with its carrying amount and an impairment charge will be recognized for the amount that the carrying value exceeds the fair value of the reporting unit. A reporting unit is the level of reporting at which goodwill is tested for impairment. The Company has three reporting units: CooperVision, and within the CooperSurgical segment, Office/Surgical and Fertility, reflecting the current way the Company manages its business.

Goodwill impairment analysis and measurement is a process that requires significant judgment. If the Company's common stock price trades below book value per share, there are changes in market conditions or a future downturn in its business, or a future goodwill impairment test indicates an impairment of our goodwill, the Company may have to recognize a non-cash impairment of goodwill that could be material and could adversely affect the Company's results of operations in the period recognized and also adversely affect its total assets and stockholders' equity.

The Company considered the impact on its near and long-term forecasts from the general deterioration of economic and market conditions as a result of higher inflation, regional and global conflict, supply chain disruption, and the ongoing disruptions of COVID-19 pandemic. Based on our assessment, we determined that it was not more likely than not that the fair value of reporting units or relevant asset groups was below carrying amounts. Therefore, there was no impairment to goodwill at July 31, 2022.

Other Intangible Assets


	July 31, 2022				October 31, 2021
(In millions)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization		Weighted Average Amortization Period (in years)

Intangible assets with definite lives:
Customer relationships	$	1,098.1	$	274.0	$	378.4	$	240.1	13
Composite intangible asset	1,061.9		336.3		1,061.8		283.2		15
Technology	504.0		308.5		513.0		287.9		10
Trademarks	210.4		59.0		156.7		49.1		14
License and distribution rights and other	32.8		22.9		33.4		21.6		11
	2,907.2		$	1,000.7	2,143.3		$	881.9	13
Less: accumulated amortization and translation	1,000.7				881.9
Intangible assets with definite lives, net	1,906.5				1,261.4
Intangible assets with indefinite lives, net (1)	10.8				10.1
Total other intangibles, net	$	1,917.3			$	1,271.5

(1) Intangible assets with indefinite lives include technology and trademarks.

Balances include foreign currency translation adjustments.

Intangible assets with definite lives are amortized over the estimated useful life of the assets. As of July 31, 2022, the estimate of future amortization expenses for intangible assets with definite lives is as follows:


Fiscal Years:	(In millions)
Remainder of 2022	$	51.9
2023	206.1
2024	202.1
2025	192.2
2026	184.9
Thereafter	1,069.3
Total remaining amortization for intangible assets with definite lives	$	1,906.5

The Company assesses definite-lived intangible assets whenever events or changes in circumstances indicate that the carrying amount of a definite-lived intangible asset (asset group) may not be recoverable. When events or changes in circumstances indicate that the carrying amount of a definite-lived intangible asset may not be recoverable, in accordance with related accounting standards, the Company evaluates whether the definite-lived intangible asset is impaired by comparing its carrying value to its undiscounted future cash flows.

The Company assesses indefinite-lived intangible assets annually in the third quarter of the fiscal year, or whenever events or circumstances indicate that the carrying amount of an indefinite-lived intangible asset (asset group) may not be recoverable. The Company evaluates whether the indefinite-lived intangible asset is impaired by comparing its carrying value to its fair value.

The Company determined that there was no impairment to indefinite-lived and definite lived intangible assets at July 31, 2022. There was an immaterial impairment charge related to our exit from the contact lens care business. Refer to Note 1. General for further information.